PMC:7309518 / 4547-4941
Annnotations
LitCovid-PD-MONDO
{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T83","span":{"begin":329,"end":337},"obj":"Disease"}],"attributes":[{"id":"A83","pred":"mondo_id","subj":"T83","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"ing severe respiratory compromise soon after the median 4-day incubation period5 and underrecognition of neurologic events owing to overwhelming urgency to focus on life-saving efforts is unclear. In the most up-to-date large published series, apart from multifactorial acute cerebrovascular events in 5.7% of patients, the main COVID-19–related neurologic symptoms have been hypogeusia (in 5.6"}
LitCovid-PD-CLO
{"project":"LitCovid-PD-CLO","denotations":[{"id":"T28","span":{"begin":156,"end":161},"obj":"http://purl.obolibrary.org/obo/CLO_0009985"}],"text":"ing severe respiratory compromise soon after the median 4-day incubation period5 and underrecognition of neurologic events owing to overwhelming urgency to focus on life-saving efforts is unclear. In the most up-to-date large published series, apart from multifactorial acute cerebrovascular events in 5.7% of patients, the main COVID-19–related neurologic symptoms have been hypogeusia (in 5.6"}
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"175","span":{"begin":310,"end":318},"obj":"Species"},{"id":"183","span":{"begin":255,"end":291},"obj":"Disease"},{"id":"184","span":{"begin":329,"end":337},"obj":"Disease"},{"id":"185","span":{"begin":376,"end":386},"obj":"Disease"}],"attributes":[{"id":"A175","pred":"tao:has_database_id","subj":"175","obj":"Tax:9606"},{"id":"A183","pred":"tao:has_database_id","subj":"183","obj":"MESH:D020521"},{"id":"A184","pred":"tao:has_database_id","subj":"184","obj":"MESH:C000657245"},{"id":"A185","pred":"tao:has_database_id","subj":"185","obj":"MESH:D000370"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ing severe respiratory compromise soon after the median 4-day incubation period5 and underrecognition of neurologic events owing to overwhelming urgency to focus on life-saving efforts is unclear. In the most up-to-date large published series, apart from multifactorial acute cerebrovascular events in 5.7% of patients, the main COVID-19–related neurologic symptoms have been hypogeusia (in 5.6"}
LitCovid-PD-HP
{"project":"LitCovid-PD-HP","denotations":[{"id":"T30","span":{"begin":376,"end":386},"obj":"Phenotype"}],"attributes":[{"id":"A30","pred":"hp_id","subj":"T30","obj":"http://purl.obolibrary.org/obo/HP_0000224"}],"text":"ing severe respiratory compromise soon after the median 4-day incubation period5 and underrecognition of neurologic events owing to overwhelming urgency to focus on life-saving efforts is unclear. In the most up-to-date large published series, apart from multifactorial acute cerebrovascular events in 5.7% of patients, the main COVID-19–related neurologic symptoms have been hypogeusia (in 5.6"}